Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR2 | O15552 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 6/20 | 0.55 |
| ▸ | NPC1 | O15118 | 5/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | NAMPT | P43490 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
| ▸ | AHR | P35869 | 1/20 | 0.51 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7874804 | 0.98 | FFAR2 (0.54) | FFAR2RAB9ANPC1HTTSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL7868142 | 0.98 | FFAR2 (0.54) | FFAR2RAB9ANPC1HTTSMN1; SMN2 | |
| SCHEMBL22939497 | 0.84 | HTT (0.61) | FFAR2RAB9ANPC1HTTSMN1; SMN2 | |
| SCHEMBL1800442 | 0.84 | HTT (0.61) | FFAR2RAB9ANPC1HTTSMN1; SMN2 | |
| Iodide SCHEMBL3094071 | 0.83 | HTT (0.59) | FFAR2RAB9ANPC1HTTSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL8009982 | 0.83 | HTT (0.59) | FFAR2RAB9ANPC1HTTSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL8009979 | 0.83 | HTT (0.59) | FFAR2RAB9ANPC1HTTSMN1; SMN2 | |
| SCHEMBL6625479 | 0.82 | CIT (0.52) | FFAR2HTTSMN1; SMN2LMNA | |
| SCHEMBL7425368 | 0.82 | CIT (0.52) | FFAR2HTTSMN1; SMN2LMNA | |
| SCHEMBL8396733 | 0.82 | MAPT (0.57) | RAB9ANPC1HTTSMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6329400-B1 | INHIBITION OR ANTAGONISM OF MATRIX METALLOPROTEASES, AND/OR TUMOR NECROSIS FACTOR-ALPHA; EXTRACELLULAR MATRIX DEGRADATION, INHIBITION OF SHEDDING OF CELL SURFACE PROTEIN ECTODOMAINS AND CD23 PROTEOLYSIS | GLAXO WELLCOME INC. | 2001-12-11 | — | — | US | claimed |
| US-6329400-B1 | INHIBITION OR ANTAGONISM OF MATRIX METALLOPROTEASES, AND/OR TUMOR NECROSIS FACTOR-ALPHA; EXTRACELLULAR MATRIX DEGRADATION, INHIBITION OF SHEDDING OF CELL SURFACE PROTEIN ECTODOMAINS AND CD23 PROTEOLYSIS | GLAXO WELLCOME INC. | 2001-12-11 | — | — | US | disclosed |